Elevance Health (ELV) News

Elevance Health (ELV): $400.77

3.29 (+0.83%)

POWR Rating

Component Grades

Momentum

D

Stability

B

Sentiment

Quality

C

Add ELV to Watchlist
Sign Up

Filter ELV News Items

ELV News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ELV News Highlights

  • For ELV, its 30 day story count is now at 20.
  • Over the past 21 days, the trend for ELV's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
  • The most mentioned tickers in articles about ELV are TOP, ACT and FSR.

Latest ELV News From Around the Web

Below are the latest news stories about ELEVANCE HEALTH INC that investors may wish to consider to help them evaluate ELV as an investment opportunity.

UNH Stock Alert: What to Know as UnitedHealth Agrees to Sell Brazil Operations

UnitedHealth remains the dominant force in the U.S. health insurance system.

Dana Blankenhorn on InvestorPlace | December 29, 2023

3 Amazing Health Service Stocks to Brave "Labordemic" in 2024

Here are the three stocks, MEDP, ELV and HQY, which have the potential to shield your portfolio from the impact of healthcare staffing challenges in 2024.

Yahoo | December 28, 2023

15 Best Group Insurance Companies Heading into 2024

In this article, we will look into the 15 best group insurance companies heading into 2024. If you want to skip our detailed analysis, you can go directly to the 5 Best Group Insurance Companies Heading into 2024. Group Health Insurance Market According to a report by Allied Market Research, the global group health insurance […]

Yahoo | December 22, 2023

ELV vs. GDRX: Which Stock Is the Better Value Option?

ELV vs. GDRX: Which Stock Is the Better Value Option?

Yahoo | December 22, 2023

Elevance Health (ELV) Stock Falls Amid Market Uptick: What Investors Need to Know

Elevance Health (ELV) concluded the recent trading session at $465.78, signifying a -0.76% move from its prior day's close.

Yahoo | December 19, 2023

AM Best Affirms Credit Ratings of Elevance Health, Inc. and Its Subsidiaries

OLDWICK, N.J., December 19, 2023--AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a+" (Excellent) of the core Blue Cross Blue Shield-branded insurance subsidiaries of Elevance Health, Inc. (Elevance) (Indianapolis, IN) [NYSE: ELV], as well as its life insurance subsidiaries. These companies collectively are referred to as Anthem Health. At the same time, AM Best has affirmed the Long-Term ICR of "bbb+" (Good),

Yahoo | December 19, 2023

Investors in Elevance Health (NYSE:ELV) have seen solid returns of 100% over the past five years

If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share...

Yahoo | December 19, 2023

Insider Sell Alert: EVP, CLO & CAO Blair Todt Sells 5,492 Shares of Elevance Health Inc

Blair Todt, the Executive Vice President, Chief Legal Officer, and Chief Administrative Officer of Elevance Health Inc (formerly known as Anthem, Inc.), has recently made a significant stock transaction, according to regulatory filings.

Yahoo | December 16, 2023

HCSC, Elevance Compete for Cigna Medicare Advantage Unit

(Bloomberg) -- Health Care Service Corp. and Elevance Health Inc. are competing to acquire Cigna Group’s business providing medical coverage to people aged 65 and over, people with knowledge of the matter said. Most Read from BloombergNetanyahu, Under Pressure Over Hostage Deaths, Vows to Press OnMike Johnson May Be the Next House Speaker to Lose His Job‘Underwater’ Car Loans Signal US Consumers Slammed by High RatesUS Navy Shoots Down 14-Drone Wave as Shippers Avoid Red SeaHarvard College Early

Yahoo | December 15, 2023

UPDATE 1-HCSC, Elevance compete for Cigna Medicare Advantage unit - Bloomberg News

Health Care Service Corp and Elevance Health are competing to acquire Cigna Group’s business providing medical coverage to those aged 65 and over, Bloomberg reported on Friday, citing people with knowledge of the matter. Cigna expects final bids for its Medicare Advantage business to be submitted next week, according to the report, with the business expected to fetch more than $3 billion. Reuters had reported in November that Cigna was exploring a sale of the business.

Yahoo | December 15, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!